Microneedling Techniques Across the Globe
Monica K. Li, MD, shares what to expect at her co-directed global microneedling techniques session at AAD 2023.
Plan Your Trip: What to do While Visiting NOLA
As sessions wrap up each day at AAD, there are numerous must-see places in New Orleans.
Christopher Bunick, MD, PhD, Previews Recently Published Sarecycline Study to be Presented at AAD
Data published in Nucleic Acids Research builds on previous studies investigating the benefits of sarecycline for acne vulgaris compared to other antibiotics.
The Weekly Roundup: March 6-10
ICYMI, this week we had stories about inspiring women in dermatology for International Women's Day, a measles outbreak in Kentucky with 200,000 exposed, sarecycline's role in treating acne vulgaris, and more.
TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists
Yale School of Medicine is a testing site for a potential new congenital ichthyosis treatment.
Sarecycline’s Lipophilicity May Explain Lower Rates of Adverse Events
Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.
Incyte Will Present Multiple Dermatology Abstracts at AAD 2023
Updates from Incyte’s dermatology portfolio include late-breaking data on ruxolitinib cream and povorcitinib for vitiligo.
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum
Novan’s expected PDUFA date is January 5, 2024.
New Positive Results of Oral IL-23 Receptor Antagonist for Psoriasis
JNJ-2113 met primary endpoints in the FRONTIER 1 clinical trial.
The Mainstream Patient: March 6
This week's edition of the Mainstream Patient features stories about understanding scalp psoriasis, biotin shampoos for healthier hair, azelaic acid for acne and rosacea treatment, and more.
The Weekly Roundup: February 27-March 3
ICYMI, this week we had stories about accepted NDAs and sBLAs for VP-102 and nivolumab, overviews of rare dermatologic diseases for National Rare Disease Day, antioxidants for vitiligo and mental health, and more.
The Mainstream Patient: March 2
This week's edition of the Mainstream Patient features stories about the misunderstanding of gua sha use, how to exfoliate the face correctly according to dermatologists, the best face sunscreens of 2023, and more.
What's Trending in Skin Care: February 2023
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of February.
Discovering Dermatology Times: February 2023
Learn more about what in-depth topics were covered in the February 2023 issue of Dermatology Times®.
Verrica Pharmaceuticals' Resubmitted NDA for VP-102 Accepted by FDA
VP-102 could be the first FDA-approved treatment for molluscum contagiosum.
FDA Accepts Bristol Myers Squibb’s sBLA for Nivolumab for Resected Stage IIB/C Melanoma
Nivolumab for completely resected stage IIB or IIC melanoma is also validated by the European Medicines Agency.
The Weekly Roundup: February 20-24
ICYMI, this week we had stories about hidradenitis suppurativa coverage at Winter Clinical Miami, an NDA submission for roflumilast foam, an overview of the 2023 Biosimilars Report from Cardinal Health, and more.
The Mainstream Patient: February 23
This week's edition of the Mainstream Patient features stories about treating dry eyelids, face masks for acne-prone skin, acne scar treatments, and more.
Bruce Feinberg, DO, Discusses 2023 Biosimilars Report From Cardinal Health
Biosimilars have been a trending topic in 2023 with 8 adalimumab biosimilars expected to hit the market this year.
Arcutis Submits NDA for Roflumilast Foam for the Treatment of Seborrheic Dermatitis
Adolescents and adults with seborrheic dermatitis may have a new topical treatment soon.
Renata Block, PA-C, Discusses Physical and Mental Wellbeing
It’s crucial for patients and health care providers to consider their personal wellbeing in their daily lives.
The Mainstream Patient: February 16
This week's edition of the Mainstream Patient features stories about quality skin care products under $20, how to address skin picking, trending mushroom skin care, and more.
Recap of South Beach Symposium 2023
Discover all topics and sessions covered at South Beach Symposium.
Nonsteroidal Treatment Options for Plaque Psoriasis
Linda Stein Gold, MD, and Jennifer Soung, MD, discuss available nonsteroidal treatment options for plaque psoriasis in this DermView series recap.
An Overview of Documented Flares in Patients With GPP
Aaron Farberg, MD, and Jeffrey Crowley, MD, take a closer look at the management and treatment of generalized pustular psoriasis.
South Beach Symposium Recap: Day 4
Catch up on coverage from the final day of South Beach Symposium.
Tirbanibulin Improves Skin in Patients with Actinic Keratosis
A poster presentation from SBS 2023 reviewed the clinician satisfaction of tirbanibulin for the treatment of actinic keratosis.
Analyzing the Gut-Skin-Brain Axis
Doris Day, MD, thoroughly discussed the up-and-coming topic of the gut-skin-brain axis related to healthy skin at SBS 2023.
Atopic Dermatitis Considerations With Peter Lio, MD
Lio shares key highlights of his atopic dermatitis sessions at South Beach Symposium.
Updates on Biologics and Atopic Dermatitis With Andrew Alexis, MD
Alexis shares take-home points from his popular sessions at South Beach Symposium.